As of 2025-06-22, the Relative Valuation of Global Blood Therapeutics Inc (GBT) is (98.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 68.49 USD, the upside of Global Blood Therapeutics Inc based on Relative Valuation is -244.4%.
The range of the Relative Valuation is (78.85) - (111.83) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 23.4x | 19.2x |
| Forward P/E multiples | 16.5x - 27.9x | 22.2x |
| Fair Price | (78.85) - (111.83) | (98.92) |
| Upside | -215.1% - -263.3% | -244.4% |
| Date | P/E |